Security key
67080T108
- Type / Class
- Equity / COM
- Total 13F shares
- 643,014
- Share change
- +14,904
- Total reported value
- $7,201,000
- Price per share
- $11.20
- Number of holders
- 10
- Value change
- +$370,284
- Number of buys
- 6
- Number of sells
- 6
Report period
Q2 2022
Institutions
10
Top holders
10
NVCT full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Nuvectis Pharma, Inc. SEC filings
Nuvectis Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080T108
Recent filing periods:
Top shareholders of NVCT - Nuvectis Pharma, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ronit Capital LLP |
13F
|
Company |
—
class O/S missing
|
550,000
|
$4,076,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
42,160
|
$312,000 | — | 31 Mar 2022 | |
| Uri Ben-Or |
3/4/5
|
Int. Principal Financial Off. |
—
class O/S missing
|
25,584
|
$283,471 | — | 08 Feb 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
14,822
|
$109,000 | — | 31 Mar 2022 | |
| Virtu Financial LLC |
13F
|
Company |
—
class O/S missing
|
11,365
|
$84,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
7,872
|
$59,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
1,750
|
$13,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
141
|
$1,000 | — | 31 Mar 2022 |
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2022
As of 30 Jun 2022,
Nuvectis Pharma, Inc. - COM (NVCT) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
643,014 shares.
The largest 10 holders included
Ronit Capital LLP, BALDWIN BROTHERS LLC/MA, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., Tower Research Capital LLC (TRC), MORGAN STANLEY, and UBS Group AG.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
7
Q2 2022 holders
10
Holder diff
3
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.